Abstract
The aim: the effectiveness of the treatment tuberculosis combined with HIV infection in TB facilities of the Federal Penitentiary Service (FSIN), depending on the type of drug resistance. Materials and methods. 239 prisoners sick TB with HIV co-infection. Age: from 19 to 56 years. Results. At 50% Patients with tuberculosis, co-infected with HIV infection at Anti-tuberculosis Institution Federal Penitentiary Service will be discontinued as a result of bacterial excretion microscopy within 2 months with drug-sensitive Mycobacterium tuberculosis (Mb) 3 months from the mono-and poly-resistant and 4 months multidrug resistant (MDR). By results of seeding for 3 months drug-sensitive Mb, mono-and poly-resistant; and 4 months MDR. Will be closed cavity disintegration within 3 months from the mono-resistant, 4 months for drug-sensitive Mb, 5 months with poly- and MDR Mb.
Highlights
THE EFFECTIVENESS OF THE TREATMENT OF TUBERCULOSIS, COMBINED WITH HIV INFECTION IN THE TB FACILITY OF THE FEDERAL PENITENTIARY
The aim: the effectiveness of the treatment tuberculosis combined with HIV infection in TB facilities of the Federal Penitentiary Service (FSIN), depending on the type of drug resistance
At 50% Patients with tuberculosis, co-infected with HIV infection at Anti-tuberculosis Institution Federal Penitentiary Service will be discontinued as a result of bacterial excretion microscopy within 2 months with drug-sensitive Mycobacterium tuberculosis (Mb) 3 months from the mono-and poly-resistant and 4 months multidrug resistant (MDR)
Summary
THE EFFECTIVENESS OF THE TREATMENT OF TUBERCULOSIS, COMBINED WITH HIV INFECTION IN THE TB FACILITY OF THE FEDERAL PENITENTIARY. Значения оценок Каплана–Мейера частоты прекращения бактериовыделения, по результатам микроскопии, у больных туберкулезом, сочетанным с ВИЧ-инфекцией, в противотуберкулезном учреждении ФСИН после лечения в стационаре оказались равными в зависимости от вида ЛУ (ЛЧ, МР, ПР, МЛУ МБТ соответственно): 100,0, 100,0, 92,3, 88,9%.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
